HEAD AND NECK CANCERS
Clinical trials for HEAD AND NECK CANCERS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: IDE161 trial opens
Disease control Recruiting nowThis early-phase study tests a new drug called IDE161, alone or with another drug (pembrolizumab), in people with advanced solid tumors (like breast, ovarian, prostate, or lung cancer) that have not responded to other treatments. The main goals are to check safety, find the right…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Virus therapy targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called IDOV-Immune, a virus designed to infect and kill cancer cells while boosting the immune system. It is for adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have not responded to standard treatm…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called VMD-928, taken as a pill, either alone or with pembrolizumab (an immunotherapy), in adults with advanced solid tumors or lymphoma that have stopped responding to standard treatments. The goal is to find safe doses and see if the drug c…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug EPI-326 enters human testing for tough cancers
Disease control Recruiting nowThis early-stage study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head and neck cancer. The main goal is to find a safe dose and check for side effects. Researchers will also measure drug levels in the blood…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Sharper images could make cancer radiation more precise
Knowledge-focused Recruiting nowThis study tests a new type of CT scan (HyperSight) that may produce clearer images during radiation therapy for cancer. About 50 adults with various cancers will get extra scans to see if the new method improves image quality and could help doctors plan treatment more accurately…
Matched conditions: HEAD AND NECK CANCERS
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated May 16, 2026 22:28 UTC
-
New study maps patient journeys after major facial surgery
Knowledge-focused Recruiting nowThis study follows 200 adults with head and neck cancer who need facial reconstruction using a bone flap from another body part. Researchers will analyze national health records to map typical care patterns, including hospital visits and medications. The goal is to better underst…
Matched conditions: HEAD AND NECK CANCERS
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC